SCHELLING CHRIS (President and Chief Executive) purchased 43.3% of their position (819.67K shares) of ACER THERAPEUTICS INC. on the open market
Open‑market purchase worth $1000.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/1/2022ACC: 0001209191-22-059174
DirectorOfficer· President and Chief Executive
Since Feb 2019
+819.67K
Net shares
Net buyer
$1000.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
819.67K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+819.67K
Price / share
$1.22
Trade value
$1000K
% of position
43.3%
11/29/2022
1.89M→2.71M
Total
Net shares
+819.67K
Net value
$1000K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/29/2022 | P · Purchase | +819.67K | $1.22 | $1000K | 43.3% | 1.89M | 2.71M |
| Total | +819.67K | $1000K | ||||||
Derivative Transactions0
No derivative transactions reported